Irfan Saadi, Ph.D
Associate Professor
Cell Biology and Physiology
University of Kansas Medical Center
Kansas City, Kansas, United States
Michael Washburn, Ph.D
Professor
Cancer Biology
University of Kansas Medical Center
Kansas City, Kansas, United States
Advanced quantitative proteomic technologies provide deep insight into the proteins, pathways, and posttranslational modifications that regulate biological systems. These changes at the protein are often poorly correlated with changes in the genome, and proteome level changes in posttranslational modifications can only be captured using proteomic technologies. Extensive research has been conducted using proteomics technologies to study specific mammalian organs and tissues, for example, under normal and diseased states. The growing application of quantitative proteomics to the study of larger biological systems is especially important when considering the continued burden of human heart disease, neurological disease, and cancer. In this symposium the speakers will present work describing how quantitative proteomic technologies can be used to study the dynamics of anatomical systems. Each of the speakers will present their work on complex mammalian systems including the heart and heart disease (Dr. Rebekah Gundry, Professor), nervous system and neurological disease (Dr. Jeff Savas, Assistant Professor) and pulmonary fibrosis and pulmonary diseases (Dr. Michael Washburn, Professor). Attendees of the symposium will learn about state-of-the-art quantitative proteomics analyses which will enable their ability to apply these technologies to their research programs.
Speaker: Rebekah Gundry – University of Nebraska Medical Center
Speaker: Jeffrey N. Savas, Ph.D – Northwestern University Feinberg School of Medicine
Speaker: Michael Washburn, Ph.D – University of Kansas Medical Center
